TERESA PINCUS: Open Payments
NPI 1710214499 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 55 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $479 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $243 |
| AstraZeneca Pharmaceuticals LP | 9 | $170 |
| Amgen Inc. | 9 | $137 |
| Lilly USA, LLC | 5 | $78 |
| Phathom Pharmaceuticals, Inc. | 7 | $63 |
| Astellas Pharma US Inc | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $35 |
| Exact Sciences Corporation | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
Products named: Ozempic, AIRSUPRA, OTEZLA, MOUNJARO, Rybelsus, VOQUEZNA, FARXIGA, Veozah.
Industry payments across NJ — which companies pay providers there.
